Skip to main content
Premium Trial:

Request an Annual Quote

Metabolon Providing Murdock Institute Access to its Metabolomics Technology

NEW YORK (GenomeWeb News) – Metabolon and the David H. Murdock Research Institute today announced a deal to provide the Murdock Institute access to Metabolon's metabolomics biomarker discovery and profiling platform.

Metabolon's platform provides a metabolite survey of more than 4,000 biochemicals and complements the Murdock Institute's mass spectrometry and NMR-based metabolomics services, the two companies said, adding the deal will give the institute's partners additional resources for metabolomics.

Metabolon's technology pinpoints active metabolomic pathways "which can be further interrogated by targeted and or customized approaches offered by the [Murdock Institute] team" Metabolon and the Murdock Institute said.

Financial and other terms of the deal were not disclosed.

"This agreement leverages the strengths of our organizations to best serve [Murdock Institute] collaborators to understand metabolism and ultimately answer key research questions and deliver healthy food products for consumers," Metabolon Senior VP of Sales and Marketing Chris Bernard said in a statement.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.